[1] Knight SB, Crosbie PA, Balata H, et al.Progress and prospects of early detection in lung cancer[J]. Open Biology, 2017, 7(9): 170070.
[2] Maeda Y, Tsuchiya T, Hao H, et al.Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung[J]. J Clin Invest, 2012, 122(12): 4388-4400.
[3] Snyder EL, Watanabe H, Magendantz M, et al.Nkx2-1 Represses a Latent Gastric Differentiation Program in Lung Adenocarcinoma[J]. Molecular Cell, 2013, 50(2): 185-199.
[4] Liu Z, Yanagisawa K, Griesing S, et al.TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas[J]. Oncogene, 2017, 36(26): 3740-3748.
[5] Civitareale D, Lonigro R, Sinclair AJ, et al.A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter[J]. EMBO J, 1989, 8(9): 2537-2542.
[6] Guazzi S, Price M, De Felice M, et al.Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity[J]. EMBO J, 1990, 9(11): 3631-3639.
[7] Park SH, Yu KL, Jung YM, et al.Investigation of functional roles of transcription termination factor-1 (TTF-I) in HIV-1 replication[J]. BMB Rep, 2018, 51(7): 338-343.
[8] Li C, Cai J, Pan Q, et al.Two Functionally Distinct Forms of NKX2.1 Protein Are Expressed in the Pulmonary Epithelium[J]. Biochem Biophys Res Commun, 2000, 270(2): 462-468.
[9] Costa RH, Kalinichenko VV, Lim L.Transcription factors in mouse lung development and function[J]. Am J Physiol Lung Cell Mol Physiol, 2001, 280(5): L823-L838.
[10] Guazzi S, Lonigro R, Pintonello L, et al.The thyroid transcription factor-1 gene is a candidate target for regulation by Hox proteins[J].EMBO J, 1994, 13(14): 3339-3347.
[11] Yan C, Whitsett JA.Protein Kinase A Activation of the Surfactant Protein B Gene Is Mediated by Phosphorylation of Thyroid Transcription Factor 1[J]. J Biolo Chem, 1997, 272(28): 17327-17332.
[12] Huang H, Shi Y, Liang B, et al.Iodinated TG in Thyroid Follicular Lumen Regulates TTF-1 and PAX8 Expression via TSH/TSHR Signaling Pathway[J]. J Cell Biochem, 2017, 118(10): 3444-3451.
[13] Yang L, Yan D, Bruggeman M, et al.Mutation of a Lysine Residue in a Homeodomain Generates Dominant Negative Thyroid Transcription Factor 1[J]. Biochem, 2004, 43(39): 12489-12497.
[14] Liu J, Dong S, Li L, et al.The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system[J]. Cellular Signalling, 2019, 58: 91-98.
[15] Casals C, Campanero-rhodes MA, García-fojeda B, et al. The Role of Collectins and Galectins in Lung Innate Immune Defense[J]. Front Immunol, 2018, 9:1998.
[16] Hobi N, Giolai M, Olmeda B, et al.A small key unlocks a heavy door: The essential function of the small hydrophobic proteins SP-B and SP-C to trigger adsorption of pulmonary surfactant lamellar bodies[J]. Biochim Biophys Acta, 2016, 1863(8): 2124-2134.
[17] Laucho-contreras ME, Polverino F, Tesfaigzi Y, et al. Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD)[J]. Expert Opinion on Therapeutic Targets, 2016, 20(7): 869-883.
[18] Beers MF, Mulugeta S.The biology of the ABCA3 lipid transporter in lung health and disease[J]. Cell and Tissue Research, 2017, 367(3): 481-493.
[19] Kim HS, Kim JH, Han B, et al.Correlation of Thyroid Transcription Factor-1 Expression with EGFR Mutations in Non-Small-Cell Lung Cancer: A Meta-Analysis[J].Medicina(Kaunos), 2019, 55(2): 41.
[20] Tata PR, Chow RD,Saladi SV, et al.Developmental History Provides a Roadmap for the Emergence of Tumor Plasticity[J].Developmental Cell, 2018, 44(6): 679-693.
[21] Miyauchi E, Motoi N, Ono H, et al.Distinct Characteristics of Small Cell Lung Cancer Correlate With Central or Peripheral Origin: Subtyping Based on Location and Expression of Transcription Factor TTF-1[J]. Medicine (Baltimore), 2015, 94(51): e2324-e2324.
[22] Yamaguchi T, Yanagisawa K, Sugiyama R, et al.NKX2-1/
[23] TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma[J]. Cancer Cell, 2012, 21(3): 348-361.
[24] Ida L,Yamaguchi T,Yanagisawa K, et al.Receptor tyrosine kinase-like orphan receptor 1, a target of NKX2-1/TTF-1 lineage-survival oncogene, inhibits apoptosis signal-regulating kinase 1-mediated pro-apoptotic signaling in lung adenocarcinoma[J]. Cancer Science, 2016, 107(2): 155-161.
[25] Watanabe H, Francis JM, Woo MS, et al.Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target[J]. Genes Development, 2013, 27(2): 197-210.
[26] Ueda M, Iguchi T, Nambara S, et al.Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer[J]. Ann Surg Oncol, 2015, (Suppl 3): 1490-1498.
[27] Homminga I, Pieters R, Langerak AW, et al.Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia[J]. Cancer Cell, 2011, 19(4): 484-497.
[28] Kathuria H, Millien G, Mcnally L, et al.NKX2-1-AS1 negatively regulates CD274/PD-L1, cell-cell interaction genes, and limits human lung carcinoma cell migration[J]. Sci Rep, 2018, 8(1): 14418.
[29] Saito R-A, Watabe T, Horiguchi K, et al.Thyroid Transcription Factor-1 Inhibits Transforming Growth Factor-β-Mediated Epithelial-to-Mesenchymal Transition in Lung Adenocarcinoma Cells[J]. Cancer Res, 2009, 69(7): 2783-2791.
[30] Qi J, Rice SJ, Salzberg AC, et al.MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1[J]. Cell Cycle, 2012, 11(1): 177-186.
[31] Carman Man-Chung Li, Gocheva V, Oudin MJ, et al. Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasis[J]. Genes Dev, 2015, 29(17): 1850-1862.
[32] Hosono Y, Yamaguchi T, Mizutani E, et al.MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis[J]. EMBO J, 2012, 31(2): 481-493.
[33] Hosono Y, Usukura J, Yamaguchi T, et al.MYBPH inhibits NM IIA assembly via direct interaction with NMHC IIA and reduces cell motility[J]. Biochem Biophys Res Commun, 2012, 428(1): 173-178.
[34] Runkle EA, Mu D.Tight junction proteins: From barrier to tumorigenesis[J]. Cancer Letters, 2013, 337(1): 41-48.
[35] Runkle EA, Rice SJ, Qi J, et al.Occludin Is a Direct Target of Thyroid Transcription Factor-1 (TTF-1/NKX2-1)[J]. J Biol Chem, 2012, 287(34): 28790-28801. |
